OR WAIT null SECS
March 17, 2022
Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.
Viatris’ new drug-device is the first FDA-approved generic version of AstraZeneca’s Symbicort.
BioMed X and Merck KGaA, Darmstadt, Germany announced their collaboration on a research project to study T-cells and autoimmunity.
Envirotainer and Swiss WorldCargo have successfully completed the first commercial shipment using a new temperature-controlled air freight solution.
March 16, 2022
Novasep increases its production capacity for HPAPIs with an investment in its site in Le Mans, France.
EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.
Spectrum Chemical is adding twelve products to its bioCERTIFIED product line.
ProteoGenix’s new XtenCHO Transient Expression can achieve up to ten times higher yields than market-leading CHO systems.
NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.
CDMO Almac Pharma Services expanded its European ultra-low temperature packaging capabilities.